계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Bicycle Therapeutics
company
About
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
- 101 - 250
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$161.90M
Bicycle Therapeutics has raised a total of
$161.90M
in funding over 2 rounds. Their latest funding was raised on
Oct 1, 2020 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 1, 2020 | Debt Financing | $50M | 1 | — | — | Detail |
| Dec 1, 2018 | Series B | $27.90M | 1 | — | — | Detail |
| Jun 1, 2017 | Series B | $52M | 1 | — | — | Detail |
| Oct 14, 2014 | Series A | $32M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Bicycle Therapeutics is funded by 3 investors.
Hercules Capital
and Cambridge Innovation Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Hercules Capital
|
— | Debt Financing |
Cambridge Innovation Capital
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
